244,854 Shares in Aspen Aerogels, Inc. (NYSE:ASPN) Bought by Raymond James Financial Inc.

Raymond James Financial Inc. acquired a new position in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 244,854 shares of the construction company's stock, valued at approximately $2,909,000. Raymond James Financial Inc. owned approximately 0.30% of Aspen Aerogels at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of ASPN. Kovitz Investment Group Partners LLC purchased a new stake in shares of Aspen Aerogels during the 3rd quarter worth about $263,000. Morse Asset Management Inc acquired a new position in Aspen Aerogels in the third quarter worth approximately $264,000. Maven Securities LTD bought a new position in Aspen Aerogels during the third quarter valued at approximately $415,000. Journey Strategic Wealth LLC acquired a new stake in Aspen Aerogels in the fourth quarter valued at approximately $178,000. Finally, Y Intercept Hong Kong Ltd bought a new stake in Aspen Aerogels in the third quarter worth approximately $420,000. Institutional investors and hedge funds own 97.64% of the company's stock.

Aspen Aerogels Stock Performance

Shares of ASPN stock traded up $0.06 during trading hours on Wednesday, reaching $6.41. 996,306 shares of the company's stock were exchanged, compared to its average volume of 1,840,900. The business has a fifty day moving average price of $8.71 and a 200-day moving average price of $14.33. The stock has a market capitalization of $526.29 million, a P/E ratio of 40.07 and a beta of 2.28. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. Aspen Aerogels, Inc. has a fifty-two week low of $6.13 and a fifty-two week high of $33.15.

Remove Ads

Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its earnings results on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, beating the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. Analysts predict that Aspen Aerogels, Inc. will post 0.17 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on ASPN. Canaccord Genuity Group cut their price target on shares of Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating on the stock in a report on Friday, February 14th. Craig Hallum reduced their price target on Aspen Aerogels from $21.00 to $18.00 and set a "buy" rating for the company in a research report on Friday, February 14th. Barclays lowered their price objective on Aspen Aerogels from $25.00 to $13.00 and set an "overweight" rating on the stock in a report on Wednesday, February 19th. Roth Mkm reduced their target price on Aspen Aerogels from $22.00 to $16.00 and set a "buy" rating for the company in a report on Friday, February 14th. Finally, Seaport Res Ptn cut Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, February 12th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $19.11.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.